• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Heron Therapeutics (HRTX)

Common Shares
Sell: $1.21|Buy: $1.24|Change: 0.01 (0.85%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Address

4242 Campus Point Court
Suite 200
San Diego
CA
USA
92121

Telephone

+1 858 2514400

Website

https://www.herontx.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Heron Therapeutics Inc Fourth Quarter Earnings Conference Call for 20262027-02-26T08:30:00
Heron Therapeutics Inc Fourth Quarter Earnings Results for 20262027-02-26T00:00:00
Heron Therapeutics Inc Third Quarter Earnings Conference Call for 20262026-11-04T08:30:00
Heron Therapeutics Inc Third Quarter Earnings Results for 20262026-11-04T00:00:00
Heron Therapeutics Inc Second Quarter Earnings Conference Call for 20262026-08-07T08:30:00
Heron Therapeutics Inc Second Quarter Earnings Results for 20262026-08-07T00:00:00
Heron Therapeutics Inc Annual General Meeting for 20262026-06-12T09:00:00
Heron Therapeutics Inc First Quarter Earnings Conference Call for 20262026-05-06T08:00:00
Heron Therapeutics Inc First Quarter Earnings Results for 20262026-05-06T00:00:00
Heron Therapeutics Inc Annual Report for 20252026-02-27T00:00:00
Heron Therapeutics Inc Fourth Quarter Earnings Conference Call for 20252026-02-26T08:30:00
Heron Therapeutics Inc Fourth Quarter Earnings Result for 20252026-02-26T00:00:00

Previous key dates

NameKey Date
Heron Therapeutics Inc Annual Report for 20252026-02-27T00:00:00
Heron Therapeutics Inc Fourth Quarter Earnings Conference Call for 20252026-02-26T08:30:00
Heron Therapeutics Inc Fourth Quarter Earnings Result for 20252026-02-26T00:00:00
Heron Therapeutics Inc Third Quarter Earnings Conference Call for 20252025-11-04T08:30:00
Heron Therapeutics Inc Third Quarter Earnings Results for 20252025-11-04T00:00:00
Heron Therapeutics Inc Second Quarter Earnings Conference Call for 20252025-08-08T08:30:00
Heron Therapeutics Inc Second Quarter Earnings Results for 20252025-08-08T00:00:00
Heron Therapeutics Inc Annual General Meeting for 20252025-06-12T09:00:00
Heron Therapeutics Inc First Quarter Earnings Conference Call for 20252025-05-06T08:00:00
Heron Therapeutics Inc First Quarter Earnings Result for 20252025-05-06T00:00:00
Heron Therapeutics Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T08:00:00
Heron Therapeutics Inc Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
Heron Therapeutics Inc Annual Report for 20242025-02-27T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.